Tivic Health Systems, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
VBIO$0.54+6.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(in thousands, except share and per share data)
| 2025 | 2024 | |
|---|---|---|
| OPERATING EXPENSES | ||
| Research and development | $3,131 | $1,313 |
| Selling, general and administrative | 4,767 | 3,163 |
| Total operating expenses | 7,898 | 4,476 |
| Loss from operations | (7,898) | (4,476) |
| OTHER (EXPENSE) INCOME | ||
| Change in fair value of derivative liability | 28 | — |
| Interest income | 23 | 6 |
| Interest expense | (146) | — |
| Net other (expense) income | (95) | 6 |
| Net loss from operations before discontinued operations | (7,993) | (4,470) |
| Loss from discontinued operations | (885) | (1,185) |
| Net loss | $(8,878) | $(5,655) |
| Net loss per share attributed to common stockholders - basic and diluted | $(7.84) | $(19.68) |
| Weighted-average number of shares - basic and diluted | 1,155,531 | 287,370 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.